Tobacco quit program for women using an online app
Official title: Adaptation and Evaluation of a Tobacco Cessation Program: An Integrated mHealth Approach
Funded at University of Alabama at Birmingham · NIH-11535278 · Data updated 2026-11-12
A women-focused, phone-based cessation program uses a mobile app to help low-income, rural, and working women quit smoking.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | September 16, 2021 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $49,521 |
| NIH project number | 3R33CA253574-04S1 |
| Project ID | NIH-11535278 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women who smoke, have low income or educational attainment, and live in rural areas, with access to a mobile device.
✕Less likely to help
Women without access to a mobile device or who are not seeking cessation support may not benefit.
What this research studies
This project will adapt an existing community health worker–led cessation approach into a mobile-friendly program that delivers personalized support through an app. It aims to make quitting easier by combining in-person guidance with digital tools, reminders, and resources. The team will test whether the integrated mHealth approach helps more women with tobacco use disorder achieve abstinence compared with traditional program delivery.
Why it matters
Potential benefit: If successful, more women, especially in underserved communities, could quit smoking and reduce cancer risk.
How similar studies have gone: Prior work showed higher quit odds with CHW-led intervention, suggesting potential for improved outcomes with digital support.
Where this research is happening
-
University of Alabama at Birmingham
Birmingham, United States Active
Researchers
- Principal investigator: Scarinci, Isabel C — University of Alabama at Birmingham
- Study coordinator: Scarinci, Isabel C
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Exploring how Down syndrome affects optic nerve health in kids
A study using a mouse model to understand why optic nerve problems are common in children with Down syndrome and how to prevent them.
-
Global bromocriptine trial for postpartum cardiomyopathy
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with peripartum cardiomyopathy.
-
Global Bromocriptine Add-on for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding the dopamine agonist bromocriptine to standard heart failure care helps postpartum women with a specific heart condition.
-
Global Bromocriptine Trial for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding bromocriptine to standard heart-failure care helps women with postpartum cardiomyopathy.
-
Bromocriptine as add-on therapy for postpartum cardiomyopathy across multiple sites
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with postpartum cardiomyopathy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.